CP 866087

CAS No. 519052-02-9

CP 866087( —— )

Catalog No. M34559 CAS No. 519052-02-9

CP 866087 is an opioid receptor antagonist for the study of female sexual dysfunction.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1386 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CP 866087
  • Note
    Research use only, not for human use.
  • Brief Description
    CP 866087 is an opioid receptor antagonist for the study of female sexual dysfunction.
  • Description
    CP 866087 is an opioid receptor antagonist for the study of female sexual dysfunction.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    519052-02-9
  • Formula Weight
    426.57
  • Molecular Formula
    C24H30N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C)[C@]1([C@@]2([C@]1(CN(CC3(O)CC=4C(C3)=CC=CC4)C2)[H])[H])C5=CC(NS(C)(=O)=O)=CC=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CTOP

    Potent and selective μ opioid receptor antagonist (Ki values are 0.96 and >10,000 nM for μ and δ receptors respectively). Causes behavioral effects on central administration in vivo. Also increases K+ currents in rat locus ceruleus neurons in vitro via a μ receptor independent mechanism.

  • BAN ORL 24 dihydroch...

    BAN ORL 24 is a highly potent nociceptin/orphan FQ (N/OFQ) receptor (NOP) antagonist that can be used to study neurological diseases.

  • Cannabidiol

    Cannabidiol is GPR55 and weak CB1 antagonist (IC50s: 0.445 and 3.35 μM) CB2 receptor inverse agonist and inhibitor of anandamide uptake (IC50: 27.5 μM). It also a weak agonist at VR1 vanilloid receptors (EC50: 3.5 μM).